Bill

Bill > HB880


MD HB880

MD HB880
Pharmacy Benefits Administration - Maryland Medical Assistance Program and Pharmacy Benefits Managers


summary

Introduced
02/02/2024
In Committee
02/02/2024
Crossed Over
Passed
Dead
04/08/2024

Introduced Session

2024 Regular Session

Bill Summary

Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimburse the pharmacy; and altering the definition of "purchaser" for purposes of certain provisions of law regulating pharmacy benefits managers to include certain insurers, nonprofit health service plans, and health maintenance organizations.

AI Summary

This bill alters the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish, and that pharmacy benefits managers (PBMs) that contract with a pharmacy on behalf of a managed care organization are required to reimburse the pharmacy. The bill requires minimum reimbursement levels to be at least equal to the national average drug acquisition cost of the generic product plus the fee-for-service professional dispensing fee. It also expands the definition of "purchaser" for the purposes of regulating PBMs to include certain insurers, nonprofit health service plans, and health maintenance organizations. The bill provides some exceptions to these requirements, such as for pharmacies owned by or affiliated with a PBM, and for mail order pharmacies.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

House Health and Government Operations Hearing (13:00:00 2/29/2024 ) (on 02/29/2024)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...